#United States #Nashville #Hydrinity #RetaXome #retinoid

HYDRINITY's New Hydrating Retinoid Breakthrough

In a significant advance for skincare, HYDRINITY Accelerated Skin Science has published groundbreaking clinical trial results revealing its innovative product, RetaXome™ Daily Retinal Hydrator. This cutting-edge retinoid formulation is celebrated not only for its efficacy in enhancing the appearance of damaged skin but also for achieving these results without the irritation that typically accompanies retinoids.

Study Overview

Conducted over 12 weeks, the clinical study involved 20 female participants aged between 35 to 65, all experiencing mild-to-moderate photodamage. The participants utilized the RetaXome™ Daily Retinal Hydrator at night. Remarkably, every evaluation point showcased progressive improvement in their skin's condition throughout the study.

Key Findings

1. Erythema Reduction: The study noted a 68% improvement in redness by week 12 compared to baseline measurements, indicating a significant reduction in irritation.
2. Evening Skin Tone: Improvements in skin tone were visible as early as week 2, with an impressive 56% overall improvement by the end of the study.
3. Texture Enhancements: Throughout the trial, the participants demonstrated a 63% overall improvement in skin texture from baseline by week 12.
4. Reduction of Fine Lines and Wrinkles: There was a remarkable 36% improvement in fine lines and wrinkles by the end of the study.
5. High Satisfaction Rate: Notably, 95% of the participants expressed satisfaction with the product and would recommend it to others. During the course of the study, no adverse events related to the product were reported.

Scientific Insights

Dr. Michael Gold, a board-certified dermatologist and the lead investigator, highlighted the unique qualities of retinal as a potent ingredient for tackling photoaged skin. He emphasized that the challenge of irritation has historically limited the use of retinal in skincare. The clinical comprehension achieved through this study showcases the remarkable benefits of retinal therapy while mitigating the usual discomforts associated with it.

The secret behind this formulation lies in HYDRINITY's engineered biomimetic exosome platform, which is designed for the controlled release of retinal and improved penetration into the skin. By integrating this platform with Supercharged Hyaluronic Acid and plant-derived ingredients that possess antioxidant and anti-inflammatory properties, the formulation not only promotes visible results but also supports the integrity of the skin barrier.

A New Era in Skincare

Keith O'Briant, the CEO of HYDRINITY, views this study as a pivotal step in merging biotechnology with advanced skincare innovation. With the research published in the Journal of Cosmetic Dermatology, the scientific credibility of their products is firmly established, underscoring the company's mission to deliver clinical-level results with optimal skin compatibility.

About HYDRINITY Accelerated Skin Science

Since its inception, HYDRINITY has carved out its niche as the fastest-growing professional skincare brand in the U.S., according to Kline & Company. With a foundation rooted in regenerative medicine, the company has taken leaps in redefining skincare by introducing clinically backed formulations. The brand emphasizes a commitment to quality and innovation, now available across over 4,000 professional practices in the U.S. and 32 countries worldwide.

Through pioneering technologies such as Supercharged HA™, MicroFusion™, and RetaXome™, HYDRINITY continues to elevate the standards of skincare, aiming to achieve the intersection of science and cosmetic care effectively. As they expand their influence in the global skincare market, HYDRINITY invites those concerned about skin health to explore their novel range of products.

For media inquiries, interviews, or product samples, contact Rebel Gail Communications.